Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Articles

Page 4 of 51

  1. Insulin secretion and resistance are key pathophysiological factors in type 2 diabetes. However, only 55% of patients achieve long-term blood glucose treatment goals, highlighting the need to clarify the patho...

    Authors: Masahiro Ohira, Naoyuki Kawagoe, Chisato Kameyama, Yuko Kondou, Madoka Igarashi and Hajime Ueshiba
    Citation: Diabetology & Metabolic Syndrome 2025 17:144
  2. Metabolic syndrome (MetS) is a conglomerate of metabolic abnormalities including hypertension, obesity, hyperglycemia, hypertriglyceridemia, and low levels of high-density lipoprotein cholesterol (HDL-C). The ...

    Authors: Danyang Zhang, Haitao Shi, Chongcao Wei, Fenrong Chen, Pan Zhang, Xin Gao and Yan Wang
    Citation: Diabetology & Metabolic Syndrome 2025 17:143
  3. Among noncommunicable diseases, cardiovascular disease (CVD) is the leading cause of mortality and morbidity. In China, diabetes is renowned for its high incidence rate, and the body roundness index (BRI) is a...

    Authors: Youli Kong, Qian Luo, Qing Zhang and Quan Wei
    Citation: Diabetology & Metabolic Syndrome 2025 17:142
  4. Some observational studies found that there is an epidemiological association between type 2 diabetes (T2D) and sleep apnea (SA) and glucose-lowering drugs may lower SA risk. However, the causative relationshi...

    Authors: Fang Cheng, Kang Yang, Yaoling Wang, Fan Yang, Xinyu Niu and Wei Li
    Citation: Diabetology & Metabolic Syndrome 2025 17:141
  5. This study explores the causal relationships between five major lipids, 249 circulating metabolites, and four diabetic retinopathy (DR) outcomes: overall DR, background DR, severe background DR, and proliferat...

    Authors: Jiawei Wang, Jing Su, Danyan Liu and Jingxue Ma
    Citation: Diabetology & Metabolic Syndrome 2025 17:139
  6. We aimed to probe the effect of microRNA (miR)-455-3p derived from human umbilical cord mesenchymal stem cell exosomes (hucMSCs-Exos) in targeting calcium/calmodulin-dependent protein kinase 2 inhibitor 1 (CAM...

    Authors: Yan Zhang, Mingyu Du, Baosheng Zhu, Runmei Ma and Jinman Zhang
    Citation: Diabetology & Metabolic Syndrome 2025 17:138
  7. The Fasting Mimicking Diet (FMD) has gained significant attention as a potential intervention for reducing cardiovascular risk factors. While studies have investigated its effectiveness, findings have been inc...

    Authors: Milad Mohammadzadeh, Mahdi Amirpour, Hamid Ahmadirad, Fatemeh Abdi, Saman Khalesi, Niayesh Naghshi, Alireza Bahrami and Ehsan Hejazi
    Citation: Diabetology & Metabolic Syndrome 2025 17:137
  8. Social determinants of health (SDOH) and metabolic syndrome (MetS) are related, but their combined effect on mortality risk remains unclear.

    Authors: Xiaohan Ma, Sheng Chen, Lin Guo, Shuaikang Wang, Junchao Wu, Lingling Wu, Ting Zhang, Hongjun Gao and Encun Hou
    Citation: Diabetology & Metabolic Syndrome 2025 17:136
  9. Authors: Vanessa Estato, Nathalie Obadia, Paulo Henrique Chateaubriand, Vivian Figueiredo, Marcela Curty, Mariana Costa Silva, Renata Gabriela Lustosa Ferreira, Juliane Santa-Ritta, Marcela Campos Baroni, Alessandra Aragão, João Oliveira Góes Neno, Clara Avelar Mendes Vasconcellos, Joana Costa D’Avila, Marcelo Gomes Granja and Hugo Caire de Castro Faria-Neto
    Citation: Diabetology & Metabolic Syndrome 2025 17:135

    The original article was published in Diabetology & Metabolic Syndrome 2025 17:2

  10. Authors: Sichun Wen, Jingfen Li, Zheng Xie, Xiaohui Chen, Junyi Li and Xiayi Lin
    Citation: Diabetology & Metabolic Syndrome 2025 17:134

    The original article was published in Diabetology & Metabolic Syndrome 2025 17:67

  11. The effect of insulin resistance (IR) on epicardial adipose tissue (EAT) remains uncertain. This study aimed to investigate how early-stage IR influences EAT, contributing to myocardial fibrosis and left ventr...

    Authors: Runze Zhu, Wenxian Wang, Yan Gao, Jian Wang, Bowen Li, Zhenyu Cheng, Congshan Ji, Hui Gu, Xianshun Yuan, Shifeng Yang and Ximing Wang
    Citation: Diabetology & Metabolic Syndrome 2025 17:133
  12. To evaluate the effect of impaired fasting glucose (IFG) and various anti-diabetic agents on the risk of incident major cardiovascular events (MACE) in patients with inflammatory arthritis (IA) including rheum...

    Authors: Huan Meng, Ho So, Steven H. Lam and Lai-Shan Tam
    Citation: Diabetology & Metabolic Syndrome 2025 17:132
  13. Cardiovascular disease (CVD) remains a major global health challenge, particularly affected by glucose metabolism status. However, the relationship between estimated glucose disposal rate (eGDR) and future CVD...

    Authors: Xiaomin Liang, Kai Lai, Xiaohong Li, Di Ren, Shuiqing Gui, Zemao Xing and Ying Li
    Citation: Diabetology & Metabolic Syndrome 2025 17:131
  14. The prognostic value of Magnesium Depletion Score (MDS) in Diabetic Kidney Disease (DKD) patients is still unclear. This study aimed to determine the associations between MDS and long-term mortality in DKD pop...

    Authors: Lingzhi Xing, Yubowen Gong, GuoJia Liao, Liying Wang and Ling Chen
    Citation: Diabetology & Metabolic Syndrome 2025 17:130
  15. The purpose of this study is to investigate the relationship between the weight-adjusted waist index (WWI) and the incidence of carotid atherosclerotic plaque in patients with type 2 diabetes (T2DM) in the Chi...

    Authors: Yu Qin, Jing-Jing Ye, Xu-Nan Wu, Yue Xia, Hao-Xiang Li, Ling Yang, Xia Deng and Guo-Yue Yuan
    Citation: Diabetology & Metabolic Syndrome 2025 17:129
  16. Circulating immune cells reportedly affect diabetic neuropathy (DN). Although associations have been previously established between numerous biomarkers and diseases, elucidating their causal relationships rema...

    Authors: Lingfen Ji, Puyu Li, Nana Duan, Jinjin Xu, Yijuan Song, Bohui Shu, Lijun Liang and Fuli Zhao
    Citation: Diabetology & Metabolic Syndrome 2025 17:127
  17. To compare the effects of switching from dipeptidyl peptidase 4 (DPP-4) inhibitors to oral semaglutide on oxidative stress and glucose variability assessed by continuous glucose monitoring in patients with typ...

    Authors: Makoto Ohara, Hiroki Yokoyama, Hiroaki Seino, Tomoki Fujikawa, Yo Kohata, Noriyuki Takahashi, Shunichiro Irie, Michishige Terasaki, Yusaku Mori, Tomoyasu Fukui and Sho-ichi Yamagishi
    Citation: Diabetology & Metabolic Syndrome 2025 17:126
  18. Chronic low-grade inflammation and dyslipidemia are central to the development of insulin resistance (IR) and type 2 diabetes (T2D). The ratio of high-sensitivity C-reactive protein (hs-CRP) to high-density li...

    Authors: Kun Xue, Meijun Sun, Chao Zong, Shanshan Xing and Hang Xue
    Citation: Diabetology & Metabolic Syndrome 2025 17:125
  19. The global prevalence of diabetes is on an upward trajectory. The management of complications related to the condition has seen limited progress in recent years. Klotho, characterized as an anti-aging protein ...

    Authors: Kangxiang Wu, Jiaqi Chen, Yiying Lin and Jie Wang
    Citation: Diabetology & Metabolic Syndrome 2025 17:124
  20. Stroke due to large artery atherosclerosis (LAA-stroke) has a poor early prognosis despite appropriate medical treatment. Recently, various parameters reflecting pathological conditions such as insulin resista...

    Authors: Ki-Woong Nam, Hyung-Min Kwon and Yong-Seok Lee
    Citation: Diabetology & Metabolic Syndrome 2025 17:123
  21. The rising prevalence and high mortality of diabetes have made it a significant public health concern. This study explores how electroacupuncture (EA) influences the PI3K/Akt pathway and its role in regulating...

    Authors: Shaoyang Liu, Shuting Zhuang, Rui Li and Haoru Duan
    Citation: Diabetology & Metabolic Syndrome 2025 17:122
  22. Statins, a kind of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, are first-line cholesterol-lowering drugs that are widely used in the primary and secondary prevention of coronary ather...

    Authors: Hui Wang, Mulalibieke Heizhati, Nanfang Li, Lin Gan, Ling Yao, Mei Li, Li Cai, Xiufang Li, Xiayire Aierken, Dan Yu, Miaomiao Liu, Adalaiti Maitituersun, Qiaolifanayi Nuermaimaiti, Aketilieke Nusufujiang and Jing Hong
    Citation: Diabetology & Metabolic Syndrome 2025 17:121
  23. Overweight and obesity have been associated with an altered intestinal microbiome. Recent investigations have demonstrated that fiber supplementation, including chitosan, can exert beneficial and protective ef...

    Authors: Somaye Fatahi, Mohammad Hassan Sohouli, Koroush Vahidshahi, Pejman Rohani, Majid Safa, Masoud Salehi, Mihnea-Alexandru Găman and Farzad Shidfar
    Citation: Diabetology & Metabolic Syndrome 2025 17:120
  24. Obesity is a chronic and complex disease influenced by various factors that hinder weight loss and maintenance. However, perceptions of obesity are often marked by stigma. This study assessed perceptions of ob...

    Authors: Luiz F. Viola, Fabiana Mandel, Cynthia M. Valerio, Maria Augusta Bernardini and Bruno Halpern
    Citation: Diabetology & Metabolic Syndrome 2025 17:119
  25. Metabolic syndrome (MetS) is increasingly viewed as a pressing concern for public health globally. The objective of this study was to compare the predictive ability of 17 anthropometric indices for the risk of...

    Authors: Peizhen Zhou, Wei Liu, Kangning Sun, Zekun Zhao, Wenqian Zhu, Jing Zhang and Wenjun Wang
    Citation: Diabetology & Metabolic Syndrome 2025 17:118
  26. Most existing studies have primarily focused on the effects of Traditional Chinese Exercises (TCEs) on glycemic control in individuals with prediabetes, while specific recommendations for managing dyslipidemia...

    Authors: Ruixiang Yan, Wuwen Peng, Di Lu, Jiaxin He, Jian Sun, Lingju Guan, Shufang Liu and Duanying Li
    Citation: Diabetology & Metabolic Syndrome 2025 17:117
  27. Type 2 diabetes mellitus (T2DM) is known to worsen the prognosis of heart failure (HF), but its specific impact on patients with ischemic versus non-ischemic heart failure with mildly reduced ejection fraction...

    Authors: Zhican Liu, Hailong Hu, Jianping Zeng and Mingyan Jiang
    Citation: Diabetology & Metabolic Syndrome 2025 17:115
  28. Type 2 diabetes mellitus (T2DM) is a kind of metabolic disease characterized by aberrant insulin secretion as a result of -cell loss or injury, or by impaired insulin sensitivity of peripheral tissues, which f...

    Authors: Mengjuan Wei, Yan Wang, Yufei Zhang and Yun Qiao
    Citation: Diabetology & Metabolic Syndrome 2025 17:114
  29. Both type 1 and type 2 diabetes mellitus (T1D and T2D) are associated with poor bone health and an increased risk of fracture in adults. However, there are limited data regarding the effects of diabetes on the...

    Authors: Sowmya Krishnan, Christopher E. Aston, Jennifer Chadwick, Shelly Gulati, Huaiwen Wang, Susan B. Sisson, Madhusmita Misra and Steven D. Chernausek
    Citation: Diabetology & Metabolic Syndrome 2025 17:113
  30. Stress hyperglycemia ratio (SHR) has been associated with increased mortality from various cerebrovascular events and a higher incidence of acute kidney injury (AKI) in certain patient populations. However, th...

    Authors: Yue Shi, Hangyu Duan, Jing Liu, Xiujie Shi, Mingming Zhao and Yu Zhang
    Citation: Diabetology & Metabolic Syndrome 2025 17:112
  31. To date, no meta-analysis has reported on the role of transdermal estrogens combined with Medroxyprogesterone Acetate (MPA) in relation to cardiovascular disease (CVD) risk factors in postmenopausal women. To ...

    Authors: Fan Zhou, Kousalya Prabahar and Jiao Shu
    Citation: Diabetology & Metabolic Syndrome 2025 17:111
  32. Considering the important role of cardiometabolic risk factors in different societies on increasing the burden of non-communicable diseases, in this study we will investigate the possible effects of Beinagluti...

    Authors: Yan Xu, Periyannan Velu, Li Hu and Nathalia Sernizon Guimarães
    Citation: Diabetology & Metabolic Syndrome 2025 17:110
  33. The Cardiovascular-kidney-metabolic (CKM) syndrome is a health disorder caused by interactions between cardiovascular disease, kidney disease, and metabolism-related risk factors. The stress hyperglycemia rati...

    Authors: Fan-Shun Guo, Jia-Hao Dou, Jun-Xiang Wang, Chen Guo, Rui-Yun Wu, Xue-Lu Sun, Yi-Wei Hu and Jin Wei
    Citation: Diabetology & Metabolic Syndrome 2025 17:109
  34. Type 2 diabetes mellitus (T2DM) is closely associated with both environmental and genetic factors, involving multi-gene inheritance. This study examined the association between the polymorphic locus rs10757278...

    Authors: Xinyi Li, Aige Yang, Xiao Liu, Rui Zhang, Huimin Zhou and Shunjiang Xu
    Citation: Diabetology & Metabolic Syndrome 2025 17:108
  35. Fatty pancreas disease (FPD) is characterized by abnormal fat accumulation in pancreatic tissue and is often associated with obesity, metabolic syndrome, and type 2 diabetes mellitus (T2DM). While its pathophy...

    Authors: Tahsin Taner Karaevren, Refika Yorulmaz, Mahinur Cerit, Halit Nahit Şendur, Burak Kalafat, Gizem Yaz Aydın, Özlem Gülbahar, Mehmet Muhittin Yalçın, Ayhan Karakoç, Müjde Aktürk, Füsun Baloş Törüner, Alev Eroğlu Altınova, Taha Enes Çetin and Ethem Turgay Cerit
    Citation: Diabetology & Metabolic Syndrome 2025 17:107
  36. To assess the association between serum uric acid (SUA) level and the prevalence of diabetic retinopathy (DR) and chronic kidney disease (CKD) in patients with long-term diabetes.

    Authors: Hanying Wang, Liping Gu, Yuhang Ma, Xindan Xing, Yuan Qu, Xin Shi, Xinyi Liu, Hancong Wan, Qian Zhu, Yingchen Shen, Chong Chen, Li Su, Yufan Wang and Kun Liu
    Citation: Diabetology & Metabolic Syndrome 2025 17:106
  37. This study aimed to evaluate the associations between neutrophil percentage-to-albumin ratio (NPAR) and both all-cause and cardiovascular mortality in diabetic kidney disease (DKD) patients.

    Authors: Juntao Tan, Jinglong Du, Jiaxiu Liu, Wenlong Zhao and Yanbing Liu
    Citation: Diabetology & Metabolic Syndrome 2025 17:105
  38. Postherpetic neuralgia (PHN) and diabetes mellitus frequently coexist in clinical settings; however, the causal relationship between them remains unclear. Moreover, the potential mediating role of amino acids ...

    Authors: Haoning Lan, Zhangran Ai, Songchao Xu, Huili Li, Zhong Feng, Ruijuan Guo and Yun Wang
    Citation: Diabetology & Metabolic Syndrome 2025 17:104
  39. Type 2 diabetes mellitus (T2DM) is increasingly affecting people aged 15–34, posing a serious public health challenge due to its faster progression and higher complication risks. This study examines the global...

    Authors: Yang Zhou, Yupeng Chen, Yiting Tang, Shan Zhang, Zifan Zhuang and Qing Ni
    Citation: Diabetology & Metabolic Syndrome 2025 17:103
  40. Patients with diabetic nephropathy (DN) often present with lipid profile abnormalities. While associations between these parameters and DN have been suggested, confounding factors obscure causal relationships....

    Authors: Pengfei Xie, Weinan Xie, Zhaobo Wang, Ziwei Guo, Rumeng Tang, Haoyu Yang, Yu Wei, Ling Zhou, Yishan Huang, Linhua Zhao and Lili Zhang
    Citation: Diabetology & Metabolic Syndrome 2025 17:102
  41. we aimed to evaluate the association of interleukin-1β (IL-1β) gene single nucleotide polymorphisms (SNPs) and its interaction with smoking status on diabetic nephropathy (DN) risk in a Chinese Han population.

    Authors: Tianyue Xie and Zhuqi Tang
    Citation: Diabetology & Metabolic Syndrome 2025 17:101
  42. Glycemic variability (GV) is a key determinant of outcomes in critically ill patients, yet its impact on cerebral infarction patients in intensive care units (ICUs) remains underexplored. This study evaluates ...

    Authors: Hui Yang, Hongcai Wang and Yan Jiang
    Citation: Diabetology & Metabolic Syndrome 2025 17:100
  43. The non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) is a novel lipid indicator used for assessing the risk of cardiovascular diseases. This study was performed to ...

    Authors: Sikun Zhang and Zhaowei Zhu
    Citation: Diabetology & Metabolic Syndrome 2025 17:99
  44. Although studies had shown that Insulin resistance (IR) was correlated with the occurrence of sarcopenia, there were still many controversial conclusions. Therefore, we conducted a more comprehensive study on ...

    Authors: Zikai Jin, Liming Zheng, Chuanrui Sun, Bo Xu, Xiangyun Guo, Yili Zhang, Linghui Li and Xu Wei
    Citation: Diabetology & Metabolic Syndrome 2025 17:97
  45. The triglyceride-glucose (TyG) index, a recognized marker for insulin resistance, holds potential implications for skeletal health. However, its relationship with fragility fractures remains uncertain. We aime...

    Authors: Yuan Lou, Huan Chen, Fuli Man, Lina Zhang and Qi Pan
    Citation: Diabetology & Metabolic Syndrome 2025 17:96
  46. Diabetes retinopathy (DR) is a prevalent microvascular complication of type 2 diabetes mellitus (T2DM). This study investigated the correlation between renal function and DR, as well as the potential mediating...

    Authors: Youran Cai, Wanlu Qiu, Xiao Ma, Yuanting Yang, Ting Tang, Yuying Dong, Jian Chen and Qing Zhou
    Citation: Diabetology & Metabolic Syndrome 2025 17:95
  47. Few studies have evaluated changes in leukocyte telomere length (LTL) over a short time period (e.g. 1 week). LTL shortening is accelerated by exposure to inflammation and reactive oxygen species (ROS) damage.

    Authors: Janet M. Wojcicki, Elissa Epel, Jue Lin, Viva Tai, Jean-Marc Schwarz, Susan M. Noworolski, Ayca Erkin-Cakmak, Kathleen Mulligan, Alejandro Gugliucci and Rob H. Lustig
    Citation: Diabetology & Metabolic Syndrome 2025 17:94

New Content Item

The official journal of the Brazilian Diabetes Society.

Annual Journal Metrics

  • Citation Impact 
    Journal Impact Factor: 3.9 (2024)   
    5-year Journal Impact Factor: 4.3 (2024)   
    Source Normalized Impact per Paper (SNIP): 1.055 (2024)    
    SCImago Journal Rank (SJR): 1.152 (2024)

    Speed 
    Submission to first editorial decision (median days): 3
    Submission to acceptance (median days): 86

    Usage 2024
    Downloads: 1,578,920
    Altmetric mentions: 552